Isoniazid preventive therapy during infancy does not adversely affect growth among HIV-exposed uninfected children: Secondary analysis of data from a randomized controlled trial.

Isoniazid preventive therapy during infancy does not adversely affect growth among HIV-exposed uninfected children: Secondary analysis of data from a randomized controlled trial.

<h4>Background</h4>Isoniazid preventive therapy (IPT) decreases risk of tuberculosis (TB) disease; impact on long-term infant growth is unknown. In a recent randomized trial (RCT), we assessed IPT effects on infant growth without known TB exposure.<h4>Methods</h4>The infant T...

Full description

Bibliographic Details
Main Authors: Ashenafi Shumey Cherkos, Sylvia M LaCourse, Daniel A Enquobahrie, Jaclyn N Escudero, Jerphason Mecha, Daniel Matemo, John Kinuthia, Sarah J Iribarren, Grace John-Stewart
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0293708

Internet

https://doi.org/10.1371/journal.pone.0293708

Similar Items